UnannouncedVCRaise

Filed before 2025Filed 19 August 2020

TFF Pharmaceuticals, Inc. raised $25.9M

TFF Pharmaceuticals, Inc., a pharmaceuticals company based in Austin, TX, raised $25.9M in a new equity round, according to a filing dated 19 August 2020.

Raises filed before 2025 are not checked for a public announcement.

Filed
19 August 2020
Round
Equity round
Amount sold
$25.9M
Offering size
$25.9M
Investors so far
23
Based in
Austin, TX

Investors on the board

Firms come from the venture funds whose filings name a director of this company.

Who is on the board

1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.

Sign in with Google

How it compares

Larger than 79% of the 1,744 tracked raises with an amount filed in 2020, and than 68% of the 40 in pharmaceuticals.

TFF Pharmaceuticals, Inc. in public filings

FiledFilingSoldRaise
19 Aug 2020New filing$25.9MThis raise
24 Jul 2019New filing$8.17MAnother raise
27 Mar 2018New filing$14.2MAnother raise

Everything on TFF Pharmaceuticals, Inc.

More with BIOS Fund on the board

  1. ONL Therapeutics, Inc.$60MFiled before 202516 Sep 2024 · Ann Arbor, MI
  2. Actuate Therapeutics, Inc.$3MFiled before 20256 Mar 2024 · Fort Worth, TX
  3. Abilitech Medical, Inc.$2.93MFiled before 20254 Oct 2021 · Eden Prairie, MN
  4. Cognition Therapeutics Inc$1.65MFiled before 202528 Nov 2018 · Pittsburgh, PA

All 20 raises

Other unannounced rounds

  1. Thoughtform, Inc.$6.6MUnannounced · 1 day17 Sep 2026 · Palo Alto, CA
  2. ProvenAir Technologies, Inc.$488KUnannounced · 1 day17 Sep 2026 · Chicago, IL
  3. Gravitics, Inc.$17MUnannounced · 1 day17 Sep 2026 · Marysville, WA
  4. SurgiBox Inc.$486KUnannounced · 1 day17 Sep 2026 · Cambridge, MA
  5. Voxel Labs Inc.$10MUnannounced · 1 day17 Sep 2026 · San Francisco, CA
  6. DVx Atomic Co.$18.5MUnannounced · 2 days16 Sep 2026 · Boston, MA

All unannounced rounds

Seen it announced?

Send the link and the check will look at it.